The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S.
Yigenoglu TN, et al. Among authors: dal k, dal ms.
J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
J Med Virol. 2021.
PMID: 32776581
Free PMC article.